' Stepping Back From the Hype ' : A Critical Look at NGS ' Stepping Back From the Hype ' : A Critical Look at NGS

In the absence of clinical data to guide treatment decisions, oncologists should question whether identifying more tumor targets is inherently better, argues Dr Jack West.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Viewpoint Source Type: news